| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.32 | 8e-19 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |